These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4400575)

  • 1. Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Oct; 43(2):453P-454P. PubMed ID: 4400575
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of beta-adrenergic blocking drugs on myocardial function: an explanation at the subcellular level.
    Nayler WG
    Postgrad Med J; 1970 Nov; ():Suppl:90-6. PubMed ID: 4395466
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle.
    Nayler WG; Chipperfield D; Lowe TE
    Cardiovasc Res; 1969 Jan; 3(1):30-6. PubMed ID: 4391090
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of isoprenaline and beta-adrenoceptor blocking drugs on intestinal smooth muscle.
    Farmer JB; Levy GP
    Br J Pharmacol; 1970 Sep; 40(1):154P-155P. PubMed ID: 4395085
    [No Abstract]   [Full Text] [Related]  

  • 7. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
    Robson RD; Kaplan HR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 9. Excitatory and depressant effects of beta-adrenoceptor blocking agents on skeletal muscle.
    Wislicki L
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):310-7. PubMed ID: 4391894
    [No Abstract]   [Full Text] [Related]  

  • 10. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones.
    Nayler WG; Stone J; Carson V; McInnes I; Mack V; Lowe TE
    J Pharmacol Exp Ther; 1969 Feb; 165(2):225-33. PubMed ID: 4236550
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of five beta-adrenoceptor antagonists on the effect of isoprenaline and acetylcholine on human isolated smooth muscle.
    Hedges A; Turner P
    Br J Pharmacol; 1971 Feb; 41(2):426P-427P. PubMed ID: 4396707
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative and positive inotropic responses of the blood-perfused canine papillary muscle to acetylcholine.
    Endoh M; Tamura K; Hashimoto K
    J Pharmacol Exp Ther; 1970 Nov; 175(2):377-87. PubMed ID: 4394802
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the cardiac effects of several beta adrenergic blocking agents.
    Blinks JR
    Ann N Y Acad Sci; 1967 Feb; 139(3):673-85. PubMed ID: 4382727
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quinidine-like action components of beta-receptor antagonists and related substances. Experiments on isolated guinea pig papillary muscles].
    Tritthart H; Fleckenstein A; Fleckenstein B; Herbst A; Krause H
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):317-8. PubMed ID: 4390700
    [No Abstract]   [Full Text] [Related]  

  • 19. [Review of literature and experimental contribution on KO 592 a drug with beta-adrenolytic activity. II].
    Marmo E; Caputi AP; Saini RK
    Clin Ter; 1972 Jul; 62(2):117-63. PubMed ID: 4403714
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic effects of various palliative drugs for coronary insufficiency].
    Deltour G
    Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.